Full Text View
Tabular View
No Study Results Posted
Related Studies
Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
This study has been completed.
Study NCT00001905   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Adhesions
Leukocyte-Adhesion Deficiency Syndrome
Syndrome
More general conditions related to this trial
Disease
Immune System Diseases
Immunologic Deficiency Syndromes
Pathologic Processes
Interventions listed in this trial
Interferon gamma
Additional drug interventions recognized in this trial
Interferon Type II
Interferon-gamma, Recombinant
Interferons
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services